wire - news in brief

Page not found (Error 404)

Health - Oct 16
Working with clinicians from Massachusetts Eye and Ear and Harvard Medical School, a team of EPFL researchers has developed a conformable electrode implant that will allow people with a dysfunctional inner ear to hear again. This new device could replace existing auditory brainstem implants, which have a number of shortcomings.
Health - Oct 16

By identifying a protein that helps regulate blood glucose and lipids, researchers at UNIGE hope for the rapid development of treatments more effective than current insulin therapy.

Environment - Oct 16

Ecosystems provide numerous benefits, supplying food, clean water and other resources. So, it is vital that ecosystem stability is maintained in the face of disturbances such as drought, heatwaves or nutrient inputs.


Results 1 - 50 of 369.
1 2 3 4 5 8 Next »

Pharmacology - Health - 07:01
Roche’s Tecentriq in combination with Avastin increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma
First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival for the treatment of the most common form of liver cancer Data will be submitted to

Career - 18.10.2019
Promoting open science
Promoting open science
As part of its 50th anniversary celebration, EPFL is highlighting his commitment for open and reproducible research through an exceptional Open Science Day, today.

Environment - 18.10.2019

Health - Pharmacology - 18.10.2019
Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications
Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu) The Centers for Disease Control

Health - Life Sciences - 18.10.2019

Environment - 17.10.2019
"Science is always a discourse"
A number of researchers have published critical comments about an ETH Zurich study that generated a lot of interest with its quantitative assessment of the technical potential that reforestation holds for reducing CO2. In the following interview, Professor Detlef Günther, Vice President for Research and Corporate Relations, explains why he welcomes this discourse.

Chemistry - Pharmacology - 17.10.2019
Change of perspective
Change of perspective
Gerd Folkers was the first head of Critical Thinking ETH (CTETH) and left an indelible mark on the initiative.

Social Sciences - 17.10.2019

Environment - Innovation / Technology - 17.10.2019
Building renovation needs to be speeded up
Building renovation needs to be speeded up
Only one out of a hundred houses per year are renovated to make them more energy efficient - less than half the number needed to achieve the goals of the Energy Strategy 2050 for buildings. The National Research Programme "Energy" shows that the necessary technologies are available, but there is a lack of appropriate planning, building and energy laws, as well as of expertise.

Innovation / Technology - 17.10.2019

Materials Science - Chemistry - 16.10.2019

Health - Life Sciences - 16.10.2019
ETH scores highly on interdisciplinarity
Two ETH Zurich projects and one with ETH involvement have been awarded one of the coveted ERC Synergy Grants. These EU grants offer up to EUR 14 million to promote interdisciplinary collaboration on research projects. Correlations and questions in research are becoming more and more complex, which makes collabo-ration between researchers from different fields necessary.

Pharmacology - Innovation / Technology - 14.10.2019
A smart speaker helps care for the elderly at home
A smart speaker helps care for the elderly at home
Two students from EPFL have developed a smart speaker with voice-activation technology that connects patients directly to their loved ones as well as caregivers and emergency services.

Electroengineering - Music - 14.10.2019
"I teach a subject that's notoriously hard to learn"
Romain Fleury, a tenure-track assistant professor who heads the Laboratory of Wave Engineering, has been named best teacher in electrical and electronic engineering.

Chemistry - Materials Science - 14.10.2019
From the Walkman to the electric car
From the Walkman to the electric car
Three researchers share this year's Nobel Prize in Chemistry. They are being honoured for their respective contributions in research that led to today's rechargeable lithium-ion batteries - and has made our smartphones and electric cars possible in their current form.

Pharmacology - Health - 14.10.2019
Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris
Phase III PEMPHIX study shows Roche's MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris 40% of patients with pemphigus vulgaris (PV) achieved sustaine

Innovation / Technology - Agronomy / Food Science - 11.10.2019

Business / Economics - Materials Science - 11.10.2019
Using industrial waste as insulation for buildings
Using industrial waste as insulation for buildings
ETH spinoff FenX transforms industrial waste into a porous foam suitable for building insulation. Unlike other sustainable materials used for the purpose, this type of insulation is non-flammable and inexpensive to produce.

Health - Life Sciences - 11.10.2019
ERC Synergy Grant for research at the interface of viral infection and cellular regulation
ERC Synergy Grant for research at the interface of viral infection and cellular regulation
The European Research Council has awarded one of the prestigious ERC Synergy Grants - the most competitive funding scheme from ERC - to a joint research project of the Friedrich Miescher Institute for Biomedical Research, the ETH Zurich and the University of Bristol. The interdisciplinary team wants to investigate the molecular mechanisms of viral infection, which will contribute to fundamental knowledge about cellular regulation and new concepts for broad-spectrum anti-viral therapy.

Computer Science / Telecom - 10.10.2019
Bike designed with artificial intelligence breaks world speed records
Bike designed with artificial intelligence breaks world speed records
An aerodynamic bike that was designed using software from Neural Concept, a spin-off from the Computer Vision Laboratory (CVLab) in the EPFL School of Computer and Communication Sciences, has broken two world records for cycling speed.

Life Sciences - 09.10.2019
Details of Dental Wear Revealed
The teeth of mammals experience constant wear. However, the details of these wear processes are largely unknown. Researchers at the University of Zurich have now demonstrated that the various areas of herbivores' teeth differ in how susceptible they are to dental wear, detailing an exact chronology.

Architecture - 08.10.2019
A new anthology highlights the legacy of Rem Koolhaas
A new anthology highlights the legacy of Rem Koolhaas
"I regard myself as a descendent of the true Modernists," a young Rem Koolhaas told Dutch journal wonen-TA/BK in 1978.

Materials Science - 08.10.2019

Health - Life Sciences - 08.10.2019
Prostate cancer research, important SNF grant goes to the IOR
The Prostate cancer biology Group, led by Dr. Giuseppina Carbone at the Institute of Oncology Research (IOR, affiliated to USI Università della Svizzera italiana), has received a 4-year grant

Event - Life Sciences - 08.10.2019

Pharmacology - Health - 08.10.2019
Novartis receives FDA approval for Beovu , offering wet AMD patients vision gains and greater fluid reductions vs aflibercept
In two head-to-head clinical trials, patients on Beovu (brolucizumab) achieved vision gains that were non-inferior to aflibercept at year one with longer treatment intervals in a majority of patients

Electroengineering - Business / Economics - 07.10.2019
Built-in expiry date
Built-in expiry date
Whether mobile phone or automatic toilets - electronic devices are becoming increasingly complex. And who hasn't heard stories of devices that fail precisely after the warranty has expired?

Career - Materials Science - 07.10.2019

Innovation / Technology - Computer Science / Telecom - 07.10.2019
Deep learning, prefabricated
Deep learning, prefabricated
Self-driving cars, the automatic detection of cancer cells, online translation: deep learning makes it all possible. The ETH spin-off Mirage Technologies has developed a deep learning platform that aims to help start-ups and companies more quickly develop and optimise their products. The name has a fairytale feel to it, with its reference to mirages and the suggestion of illusion.

Pharmacology - Life Sciences - 05.10.2019
AveXis presents updated STRONG data at WMS demonstrating a higher mean increase in Hammersmith Functional Motor Scale-Expanded (HFMSE) scores among older SMA Type 2 patients following one-time intrathecal administration of AVXS-101
Older patients (= 2 years and < 5 years) achieved a mean increase of 5.9 points from baseline in HFMSE scores, nearly double the clinically meaningful threshold (at a mean duration of follo

Astronomy / Space Science - Environment - 04.10.2019
Taking sustainability into space
Things are changing in outer space: it is filling with debris, attracting private companies, and raising new technological challenges.

Computer Science / Telecom - Career - 03.10.2019
New Microsoft research laboratory collaborates with ETH Zurich
New Microsoft research laboratory collaborates with ETH Zurich
These days, Microsoft officially opens a lab in Zurich dedicated to researching mixed reality technologies and artificial intelligence.

Linguistics / Literature - 03.10.2019
The urban writer
The urban writer
Marc Angélil played a decisive role in shaping the teaching of architecture at ETH Zurich, both as professor and as temporary head of the department.

Pharmacology - Health - 02.10.2019
Novartis positive 52-week PREVENT data confirm Cosentyx efficacy in addressing entire axSpA spectrum
Phase III PREVENT study met 52-week primary endpoint of ASAS40, showing a sustained response in patients with non-radiographic axial spondyloarthritis (nr-axSpA)   Novartis plans FDA submission for nr-axSpA, having submitted to EMA previously.

Pharmacology - Health - 01.10.2019
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Multiyear alliance underpins the Novartis commitment to leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized Novartis to establish

Pharmacology - Health - 30.09.2019
Roche presents positive Phase III results for Tecentriq (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer
Roche presents positive Phase III results for Tecentriq (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer IMvigor130 is the fi

Health - Life Sciences - 30.09.2019
Young USI researchers on stage at the first Ph.D Biomed Day
Young USI researchers on stage at the first Ph.D Biomed Day
They are 16, determined and ready to dive into the exciting world of research: the first Ph.D students from the new USI Faculty of Biomedical Sciences presented themselves on Friday 20 September at t

Pharmacology - Health - 30.09.2019
Novartis announces positive results from Phase III PALLADIUM study of inhaled combination QMF149 in patients with uncontrolled asthma
Once-daily QMF149 demonstrated superior improvement in lung function versus mometasone furoate, meeting primary endpoint PALLADIUM is part of Phase III PLATINUM clinical development program, which ev

Health - Pharmacology - 30.09.2019
Roche to present results of first prospective trial using blood-based next generation sequencing which successfully identifies people for treatment with Alecensa
Efficacy of Alecensa (alectinib) in people identified to have ALK-positive non-small cell lung cancer using liquid biopsy is consistent with efficacy in those identified by tissue analysis in the pivotal Phase III ALEX study Roche will today announce positive results from a single-arm cohort of the Phase II/III Blood First Assay Screening Trial (BFAST), the first prospective study to use only blood-based next generation sequencing (NGS) to detec
1 2 3 4 5 8 Next »